Skip to main content
HairCited

ニュートラフォル 男性型・女性型脱毛症(AGA)

A

合計1,658名の参加者を対象とした3件の研究(メタアナリシス1件を含む)に基づく。3件中3件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dnutrafol\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

Early research is consistently positive, suggesting Nutrafol may support hair growth in androgenetic alopecia, though the evidence base is still relatively small.

  • All 3 studies show positive effects, including 1 meta-analysis
  • Included in network meta-analyses comparing dietary supplements for hair loss
  • 1,658 total participants across available studies
  • More independent research is needed to confirm these findings

Key Study Findings

systematic review n=1658 Double-blind
Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis.
Dose: various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami vs: Placebo 効果: None None
review
Nutraceuticals for Androgenetic Alopecia.
Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling vs: Placebo 効果: None None
systematic_review_meta_analysis 24 weeks
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …
Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal vs: Placebo 効果: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D statistically significant for

Key Statistics

3

研究数

1658

参加者数

Positive

A

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

hairloss:
4 capsules/day

上限量: Not established

研究で検討された用量

用量 期間 効果 N
various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami -- Positive 1658
Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling -- Positive --
ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal 24 weeks Positive --

推奨摂取タイミング: 4 capsules together with a meal

Safety & Side Effects

報告されている副作用

  • Mild gastrointestinal discomfort
  • Headache (possibly from ashwagandha)
  • Allergic reactions in individuals sensitive to any component
  • Potential thyroid stimulation from ashwagandha

既知の相互作用

  • Thyroid medications (ashwagandha may affect thyroid function)
  • Anticoagulants (curcumin and saw palmetto may increase bleeding risk)
  • Immunosuppressants (ashwagandha may stimulate immune activity)
  • Sedatives and anxiolytics (ashwagandha has calming properties)

耐容上限摂取量: Not established

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does ニュートラフォル help with 男性型・女性型脱毛症(AGA)?
Based on 3 studies with 1,658 participants, there is strong evidence from multiple clinical trials that ニュートラフォル may support 男性型・女性型脱毛症(AGA) management. Our evidence grade is A (Strong Evidence).
How much ニュートラフォル should I take for 男性型・女性型脱毛症(AGA)?
Studies have used various dosages. A commonly studied range is 4 capsules/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of ニュートラフォル?
Reported side effects may include Mild gastrointestinal discomfort, Headache (possibly from ashwagandha), Allergic reactions in individuals sensitive to any component, Potential thyroid stimulation from ashwagandha. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for ニュートラフォル and 男性型・女性型脱毛症(AGA)?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 3 peer-reviewed studies with 1,658 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。